Categorizing immune responders with fusion metrics and simulation for association to survival & progression free survival with immune response in HLA-A2+ patients with GBM from a phase 2 trial of dendritic cell (DC) immunotherapy (ICT-107).
Mathematics Faculty Proceedings, Presentations, Speeches, Lectures
Part of the Mathematics Commons
Works by Anthony Gringeri in Mathematics
2016
2015
Statistically significant association of glioblastoma immunotherapy phase II clinical study (ICT-107) treatment and survival to immune response using a novel comprehensive ELISPOT analysis.
Mathematics Faculty Proceedings, Presentations, Speeches, Lectures